Volume 10, Number 2, 139-141, DOI: 10.1007/s10238-009-0074-9

An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes

Miwako Tsunosue, Naomi Mashiko, Yhukou Ohta, Yoshito Matsuo, Kouichi Ueda, Masayuki Ninomiya, Sho-ichi Tanaka, Masaru Hoshiko, Yasutsugu Yoshiyama and Masayoshi Takeuchi, et al.

View Related Documents

Abstract

Fulltext Preview

Image of the first page of the fulltext document